These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21493151)

  • 21. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.
    Humaidan P; Chin W; Rogoff D; D'Hooghe T; Longobardi S; Hubbard J; Schertz J;
    Hum Reprod; 2017 Mar; 32(3):544-555. PubMed ID: 28137754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testosterone therapy for women with poor ovarian response undergoing IVF: a meta-analysis of randomized controlled trials.
    Noventa M; Vitagliano A; Andrisani A; Blaganje M; Viganò P; Papaelo E; Scioscia M; Cavallin F; Ambrosini G; Cozzolino M
    J Assist Reprod Genet; 2019 Apr; 36(4):673-683. PubMed ID: 30610664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial.
    Lossl K; Andersen CY; Loft A; Freiesleben NL; Bangsbøll S; Andersen AN
    Hum Reprod; 2008 Aug; 23(8):1820-9. PubMed ID: 18487212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
    Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Live birth rates in Bologna poor responders treated with ovarian stimulation for IVF/ICSI.
    Polyzos NP; Nwoye M; Corona R; Blockeel C; Stoop D; Haentjens P; Camus M; Tournaye H
    Reprod Biomed Online; 2014 Apr; 28(4):469-74. PubMed ID: 24581984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve?
    Kara M; Aydin T; Aran T; Turktekin N; Ozdemir B
    Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():63-5. PubMed ID: 24331115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does the addition of growth hormone to the in vitro fertilization/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A randomized, controlled trial.
    Bassiouny YA; Dakhly DMR; Bayoumi YA; Hashish NM
    Fertil Steril; 2016 Mar; 105(3):697-702. PubMed ID: 26690008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age.
    Tannus S; Son WY; Gilman A; Younes G; Shavit T; Dahan MH
    Hum Reprod; 2017 Jan; 32(1):119-124. PubMed ID: 27852688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspirin in women undergoing in vitro fertilization treatment: a systematic review and meta-analysis.
    Khairy M; Banerjee K; El-Toukhy T; Coomarasamy A; Khalaf Y
    Fertil Steril; 2007 Oct; 88(4):822-31. PubMed ID: 17509593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
    Lainas TG; Sfontouris IA; Venetis CA; Lainas GT; Zorzovilis IZ; Tarlatzis BC; Kolibianakis EM
    Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A meta-analysis of dehydroepiandrosterone supplementation among women with diminished ovarian reserve undergoing in vitro fertilization or intracytoplasmic sperm injection.
    Li J; Yuan H; Chen Y; Wu H; Wu H; Li L
    Int J Gynaecol Obstet; 2015 Dec; 131(3):240-5. PubMed ID: 26421833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Follicle flushing does not improve live birth and increases procedure time: a systematic review and meta-analysis of randomized controlled trials.
    Martini AE; Dunn A; Wells L; Rollene N; Saunders R; Healy MW; Terry N; DeCherney A; Hill MJ
    Fertil Steril; 2021 Apr; 115(4):974-983. PubMed ID: 33676753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis.
    Coomarasamy A; Afnan M; Cheema D; van der Veen F; Bossuyt PM; van Wely M
    Hum Reprod; 2008 Feb; 23(2):310-5. PubMed ID: 18056719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant Luteinizing Hormone supplementation in poor responders undergoing IVF: a systematic review and meta-analysis.
    Fan W; Li S; Chen Q; Huang Z; Ma Q; Wang Y
    Gynecol Endocrinol; 2013 Apr; 29(4):278-84. PubMed ID: 23347045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI.
    Mohsen IA; El Din RE
    Gynecol Endocrinol; 2013 Feb; 29(2):105-8. PubMed ID: 23134528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gonadotropin-releasing hormone agonists versus antagonists for controlled ovarian hyperstimulation in oocyte donors: a systematic review and meta-analysis.
    Bodri D; Sunkara SK; Coomarasamy A
    Fertil Steril; 2011 Jan; 95(1):164-9. PubMed ID: 20684954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.
    Daya S; Gunby J
    Cochrane Database Syst Rev; 2000; (4):CD002810. PubMed ID: 11034767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria.
    Polyzos NP; Blockeel C; Verpoest W; De Vos M; Stoop D; Vloeberghs V; Camus M; Devroey P; Tournaye H
    Hum Reprod; 2012 Dec; 27(12):3481-6. PubMed ID: 22940767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
    Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
    Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count.
    Jayaprakasan K; Hopkisson J; Campbell B; Johnson I; Thornton J; Raine-Fenning N
    BJOG; 2010 Jun; 117(7):853-62. PubMed ID: 20353458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.